Nuromuscular toxicity of tyrosine kinase inhibitors in the therapy of patients with chronic myeloid leukemia

ZMORAJ, Vladimír, Daniela ŽÁČKOVÁ, Zdeněk RÁČIL, B. MIČÁNKOVÁ, Lukáš SEMERÁD, Filip RÁZGA, Tomáš JURČEK, Dana DVOŘÁKOVÁ and Jiří MAYER. Nuromuscular toxicity of tyrosine kinase inhibitors in the therapy of patients with chronic myeloid leukemia. In 18th Congress of the European Hematology Association in Haematologica. 2013.

Basic information

Original name

Nuromuscular toxicity of tyrosine kinase inhibitors in the therapy of patients with chronic myeloid leukemia

Authors

ZMORAJ, Vladimír, Daniela ŽÁČKOVÁ, Zdeněk RÁČIL, B. MIČÁNKOVÁ, Lukáš SEMERÁD, Filip RÁZGA, Tomáš JURČEK, Dana DVOŘÁKOVÁ and Jiří MAYER

Edition

18th Congress of the European Hematology Association in Haematologica, 2013

---

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology

Tags

International impact, Reviewed